Effects of icariin on hypothalamic-pituitary-adrenal axis action and cytokine levels in stressed Sprague-Dawley rats

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 12, 2006, Pages 2399-2403

  Pan, Ying ^a   Zhang, Wei Yun ^a   Xia, Xing ^a   Kong, Ling Dong ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Chronic mild stress model; Corticotropin releasing factor; Cortisol hypothalamic pituitary adrenal axis activity; Icariin; Interleukin 6; Tumor necrosis factor alpha (TNF )

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CYTOKINE; HYDROCORTISONE; ICARIIN; INTERLEUKIN 6; SUCROSE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; EPIMEDIUM; EPIMEDIUM BREVICORNUM; HORMONE BLOOD LEVEL; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; MAJOR DEPRESSION; MALE; NEUROBIOLOGY; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; STRESS;

ANIMALS; CYTOKINES; FLAVONOIDS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; STRESS;

EID: 33845371184     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.2399     Document Type: Article

References (41)

1. Nemeroff C. B., Owens M. J., CNS Spectr., 9, 23-31 (2004).
2. Kehne J., De Lombaert S., Curr. Drug Targets CNS Neurol. Disord., 1, 467-493 (2002).
3. Spreng M., Noise Health, 2, 49-58 (2000).
4. Antonijevic I. A., Psychoneuroendocrinology, Jun 8 [Epub ahead of print] (2005).
5. O'Brien S. M., Scott L. V, Dinan T. G., Hum. Psychopharmacol., 19, 397-403 (2004).
6. Kaestner F., Hettich M., Peters M., Sibrowski W., Hetzel G., Ponath G., Arolt V., Cassen U., Rothermundt M., J. Affect Disord., 87, 305-311 (2005).
7. Turnbull A. V., Rivier C., Immun., 9, 253-275 (1995).
8. Shen Y. Q., Hebert G.., Moze E., Li K. S., Neveu P. J., Neuroimmunomodulation, 12, 189-194 (2005).
9. Schiepers O. J., Wichers M. C., Maes M., Prog. Neuropsychopharmacol. Biol. Psychiatry, 29, 201-217 (2005).
10. Kuroda M., Mimaki Y., Sashida Y., Umegaki E., Yamazaki M., Chiba K., Mohri T., Kitahara M., Yasuda A., Naoi N., Xu Z. W., Li M. R., Planta Med., 66, 575-577 (2000).
11. Wu H., Lien E. J., Lien L. L., Prog. Drug Res., 60, 1-57 (2003).
12. Chen K. M., Ge B. F., Ma H. P., Liu X. Y., Bai M. H., Wang Y., Pharmazie, 60, 939-942 (2005).
13. Wang Y. K., Huang Z. Q., Pharmacol. Res., 52, 174-182 (2005).
14. Lai Z., J. LiaoNing College Traditional Chinese Medicine, 3, 266 (2001).
15. Pan Y., Kong L. D., Xia X., Zhang W. Y., Xia Z. H., Jiang F. X., Pharmacol. Biochem. Behav., 82, 686-694 (2005).
16. Zhong H. B., Pan Y., Kong L. D., Chinese Traditional and Herbal Drugs, 36, 1506-1510 (2005).
17. Willner P., Neuropsychobiology, 52, 90-110 (2005).
18. Wang M. Q., Bi Z. M., Li P., Ji H., Cheng F. L., Zhongguo Zhong Yao Za Zhi, 28, 1025-1027 (2003).
19. Willner P., Towell A., Sampson D., Sophokleous S., Muscat R., Psychopharmacology, 93, 358-364 (1987).
20. Willner P., Moreau J. L., Nielsen C. K., Papp M., Sluzewska A., Physiol. Behav., 60, 129-134 (1996).
21. Bekris S., Antoniou K., Daskas S., Papadopoulou-Daifoti Z., Behav. Brain Res., 161, 45-59 (2005).
22. Grippo A. J., Sullivan N. R., Damjanoska K. J., Crane J. W., Carrasco G. A., Shi J., Chen Z., Garcia F., Muma N. A., Van de Kar L. D., Psychopharmacology, 179, 769-780 (2005).
23. Li J. M., Kong L. D., Wang Y. M., Cheng C. H., Zhang W. Y., Tan W. Z., Life Sci., 74, 55-73 (2003).
24. Zhang W. Y., Li J. M., Zhu J. X., Shi Z. Q., Wang Y., Kong L. D., Phytother. Res., 18, 200-203 (2004).
25. Szafarczyk A., Encephale, 19, 137-142 (1993).
26. Mitchell A. J., Neurosci. Biobehav. Rev., 22, 635-651 (1998).
27. Strohle A., Holsboer F., Pharmacopsychiatry, 36, 207-214 (2003).
28. Bissette G., Klimek V., Pan J., Stockmeier C., Ordway G., Neuropsychopharmacology, 28, 1328-1335 (2003).
29. Kahl K. G., Rudolf S., Stoeckelhuber B. M., Dibbelt L., Gehl H. B., Markhof K., Hohagen F., Schweiger U., Am. J. Psychiatry, 162, 168-174 (2005).
30. Hildebrand F., Pape H. C., Krettek C., Unfallchirurg, 108, 793-794, 796-803 (2005).
31. Friedman W. J., Exp. Neurol., 168, 23-31 (2001).
32. Utsuyama M., Hirokawa K., Exp. Gerontol., 37, 411-420 (2002).
33. Hopkins S. J., Rothwell N. J., Trends Neurosci., 18, 83-88 (1995).
34. Miller D. B., O'Callaghan J. P., Metabolism, 54, 33-38 (2005).
35. Motivala S. J., Sarfatti A., Olmos L., Irwin M. R., Psychosom. Med., 67, 187-194 (2005).
36. Parissis J. T., Adamopoulos S., Rigas A., Kostakis G.., Karatzas D., Venetsanou K., Kremastinos D. T., Am. J. Cardiol., 94, 1326-1328 (2004).
37. Kahl K. G., Bester M., Greggersen W., Rudolf S., Dibbelt L., Stoeck-elhuber B. M., Gehl H. B., Sipos V., Hohagen F., Schweiger U., Psychosom. Med., 67, 407-412 (2005).
38. Wang B. L., Quan J. X., Guo S. Y., Jia H. W., Qiu M. C., Chin. J. Obstet. Gynecol., 35, 724-726 (2000).
39. Yang Z. Y., Zhong Cheng Yao, 21, 322-323 (1999).
40. Chen H., Zhang X. Z., J. Tongji Univ., 26, 5-7 (2005).
41. Liu T. H., Wang B. X., Wang Y., Guo Y. J., Wu L. J., Minami M., Nagata T., Ikejima T., Yao Xue Xue Bao, 35, 245-248 (2000).